Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Yue, Pin ^a   Chen, Zhouji ^a   Nassir, Fatiha ^a   Bernal Mizrachi, Carlos ^a   Finck, Brian ^a   Azhar, Salman ^b,c   Abumrad, Nada A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; CD36 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ANIMAL; ARTICLE; BIOSYNTHESIS; BIOTINYLATION; C57BL MOUSE; CYTOLOGY; FEMALE; LIVER; LIVER CELL; MACROPHAGE; MALE; METABOLISM; MOUSE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEIN A-I; APOLIPOPROTEINS A; ATP-BINDING CASSETTE TRANSPORTERS; BIOTINYLATION; CHOLESTEROL; FEMALE; HEPATOCYTES; LIPOPROTEINS, HDL; LIVER; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHOLIPIDS;

EID: 79952117932     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009906     Document Type: Article

References (57)

1. Su X, Abumrad NA (2009) Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab 20: 72-77.
2. Silverstein RL, Febbraio M (2009) CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2: re3.
3. Nicholson AC, Febbraio M, Han J, Silverstein RL, Hajjar DP (2000) CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci 902: 128-131; discussion 131-123.
4. Zeng Y, Tao N, Chung KN, Heuser JE, Lublin DM (2003) Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J Biol Chem 278: 45931-45936.
5. Luangrath V, Brodeur MR, Rhainds D, Brissette L (2008) Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo. Arterioscler Thromb Vasc Biol 28: 1290-1295.
6. Tall AR, Yvan-Charvet L, Terasaka N, Pagler T, Wang N (2008) HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 7: 365-375.
7. Zannis VI, Chroni A, Krieger M (2006) Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84: 276-294.
8. Calvo D, Gomez-Coronado D, Suarez Y, Lasuncion MA, Vega MA (1998) Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 39: 777-788.
9. Connelly MA, Klein SM, Azhar S, Abumrad NA, Williams DL (1999) Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 274: 41-47.
10. de Villiers WJ, Cai L, Webb NR, de Beer MC, van der Westhuyzen DR, et al. (2001) CD36 does not play a direct role in HDL or LDL metabolism. J Lipid Res 42: 1231-1238.
11. Febbraio M, Abumrad NA, Hajjar DP, Sharma K, Cheng W, et al. (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274: 19055-19062.
12. Chahil TJ, Ginsberg HN (2006) Diabetic Dyslipidemia. Endocrinology & Metabolism Clinics of North America 35: 491-510.
13. Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnan R, et al. (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555-2568.
14. Drover VA, Ajmal M, Nassir F, Davidson NO, Nauli AM, et al. (2005) CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 115: 1290-1297.
15. Goudriaan JR, den Boer MA, Rensen PC, Febbraio M, Kuipers F, et al. (2005) CD36 deficiency in mice impairs lipoprotein lipase-mediated triglyceride clearance. J Lipid Res 46: 2175-2181.
16. An P, Freedman BI, Hanis CL, Chen Y-DI, Weder AB, et al. (2005) Genomewide Linkage Scans for Fasting Glucose, Insulin, and Insulin Resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Diabetes 54: 909-914.
17. Love-Gregory L, Sherva R, Sun L, Wasson J, Schappe T, et al. (2008) Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 17: 1695-1704.
18. Havel RJ, Eder HA, Bragdon JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
19. Basu SK, Goldstein JL, Anderson GW, Brown MS (1976) Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A 73: 3178-3182.
20. Feng B, Tabas I (2002) ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 277: 43271-43280.
21. Azhar S, Tsai L, Reaven E (1990) Uptake and utilization of lipoprotein cholesteryl esters by rat granulosa cells. Biochim Biophys Acta 1047: 148-160.
22. Zhang JR, Coleman T, Langmade SJ, Scherrer DE, Lane L, et al. (2008) Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J Clin Invest 118: 2281-2290.
23. Jones C, Garuti R, Michaely P, Li WP, Maeda N, et al. (2007) Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia. J Clin Invest 117: 165-174.
24. Chen Z, Fitzgerald RL, Averna MR, Schonfeld G (2000) A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. J Biol Chem 275: 32807-32815.
25. Mehrdad H, James BM (1995) 9-cis-retinoic acid increases apolipoprotein AI secretion and mRNA expression in HepG2 cells. Atherosclerosis 117: 199-207.
26. Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119: 136-145.
27. Waddington EI, Boadu E, Francis GA (2005) Cholesterol and phospholipid efflux from cultured cells. Methods 36: 196-206.
28. Hassan HH, Bailey D, Lee D-YD, Iatan I, Hafiane A, et al. (2008) Quantitative Analysis of ABCA1-dependent Compartmentalization and Trafficking of Apolipoprotein A-I. Journal of Biological Chemistry 283: 11164-11175.
29. Drover VA, Nguyen DV, Bastie CC, Darlington YF, Abumrad NA, et al. (2008) CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice. J Biol Chem 283: 13108-13115.
30. Tall AR (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263: 256-273.
31. Nahle Z, Hsieh M, Pietka T, Coburn CT, Grimaldi PA, et al. (2008) CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/betamediated adaptation to metabolic stress. J Biol Chem 283: 14317-14326.
32. Kersten S (2008) Peroxisome proliferator activated receptors and lipoprotein metabolism. PPAR Res 132960 2008: 132960.
33. Rader DJ (2003) Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 92: 42J-49J.
34. Oram JF, Vaughan AM (2006) ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res 99: 1031-1043.
35. Chroni A, Nieland TJ, Kypreos KE, Krieger M, Zannis VI (2005) SR-BI mediates cholesterol efflux via its interactions with lipid-bound ApoE. Structural mutations in SR-BI diminish cholesterol efflux. Biochemistry 44: 13132-13143.
36. Srivastava RA (2000) Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice. Mol Cell Biochem 209: 125-129.
37. Malik S (2003) Transcriptional regulation of the apolipoprotein AI gene. Front Biosci 8: d360-368.
38. Wada T, Gao J, Xie W (2009) PXR and CAR in energy metabolism. Trends Endocrinol Metab 20: 273-279.
39. Johnson LA, Altenburg MK, Walzem RL, Scanga LT, Maeda N (2008) Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Arterioscler Thromb Vasc Biol 28: 1745-1752.
40. Linder MD, Mayranpaa MI, Peranen J, Pietila TE, Pietiainen VM, et al. (2009) Rab8 regulates ABCA1 cell surface expression and facilitates cholesterol efflux in primary human macrophages. Arterioscler Thromb Vasc Biol 29: 883-888.
41. Sun B, Boyanovsky BB, Connelly MA, Shridas P, van der Westhuyzen DR, et al. (2007) Distinct mechanisms for OxLDL uptake and cellular trafficking by class B scavenger receptors CD36 and SR-BI. J Lipid Res 48: 2560-2570.
42. Gu X, Kozarsky K, Krieger M (2000) Scavenger receptor class B, type Imediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J Biol Chem 275: 29993-30001.
43. Gu X, Trigatti B, Xu S, Acton S, Babitt J, et al. (1998) The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273: 26338-26348.
44. Connelly MA, Williams DL (2004) Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids. Curr Opin Lipidol 15: 287-295.
45. Ji Y, Wang N, Ramakrishnan R, Sehayek E, Huszar D, et al. (1999) Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 274: 33398-33402.
46. Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, et al. (1999) Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 274: 7165-7171.
47. Arai T, Rinninger F, Varban L, Fairchild-Huntress V, Liang CP, et al. (1999) Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A 96: 12050-12055.
48. Zhou J, Febbraio M, Wada T, Zhai Y, Kuruba R, et al. (2008) Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 134: 556-567.
49. Sviridov D (2009) Maturation of apolipoprotein A-I: unrecognized health benefit or a forgotten rudiment? J Lipid Res 50: 1257-1258.
50. Neufeld EB, Stonik JA, Demosky SJ, Jr., Knapper CL, Combs CA, et al. (2004) The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 279: 15571-15578.
51. Liu P, Bartz R, Zehmer JK, Ying Y, Anderson RG (2008) Rab-regulated membrane traffic between adiposomes and multiple endomembrane systems. Methods Enzymol 439: 327-337.
52. Zehmer JK, Huang Y, Peng G, Pu J, Anderson RG, et al. (2009) A role for lipid droplets in inter-membrane lipid traffic. Proteomics 9: 914-921.
53. Ducharme NA, Bickel PE (2008) Lipid droplets in lipogenesis and lipolysis. Endocrinology 149: 942-949.
54. Brasaemle DL, Dolios G, Shapiro L, Wang R (2004) Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J Biol Chem 279: 46835-46842.
55. Collot-Teixeira S, Barbatis C, Bultelle F, Koutouzis M, Pasterkamp G, et al. (2008) CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI. J Biomed Biotechnol 2008: 813236.
56. Buers I, Robenek H, Lorkowski S, Nitschke Y, Severs NJ, et al. (2009) TIP47, a Lipid Cargo Protein Involved in Macrophage Triglyceride Metabolism. Arterioscler Thromb Vasc Biol.
57. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, et al. (2004) Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler Thromb Vasc Biol 24: 504-510.